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Abstract
Objective to give an insight into the financial 
impact of the pharmacy of your choice (poyc) scheme on 
community pharmacies.
Method a time and motion study was carried out in 
three community pharmacies that are enrolled in the poyc 
scheme to provide information on the time allocated to the 
various activities pertaining to the scheme. two different 
methods were used to calculate the costs incurred to 
implement the system in the three pharmacies.
Key findings the direct costs that are related to 
the implementation of the poyc scheme are reasonably 
close to the government’s remuneration. 
Conclusion Expenses incurred due to the poyc 
scheme run into thousands of Euro every year. consequently, 
the poyc scheme does not seem to be very profitable for the 
community pharmacies where it has been implemented. 
it is highly recommended that the remuneration by the 
government ought to be revised.  
Keywords pharmacy of your choice scheme, 
pharmacist remuneration, financial impact.
Introduction
 
the pharmacy of your choice (poyc) scheme was 
introduced in 2008. the main aim of the poyc scheme was 
to reduce the long queues at the health centre government 
dispensaries. moreover, monitoring of patients by the 
community pharmacists can be improved since they ensure 
that the medicines prescribed are being administered 
correctly and more patient advice is given on a one-to-one 
basis when compared to the previous system.1 as a result 
of this poyc scheme, there is also a decrease in wastage 
because patients are not given medications if they are not 
required, even though they are entitled to them.2
the main problem associated with the poyc scheme is the 
large number of medicines that are out of stock.2 this is 
causing unnecessary stress on the pharmacists and patients. 
the poyc scheme has also affected the daily running of the 
community pharmacies where it has been introduced. due 
to the increased work load, some pharmacy owners had to 
employ additional staff. the community pharmacists who 
are involved in the implementation of the poyc scheme 
now have an increased work load and therefore do not 
provide their patients with the same service as before the 
initiation of the poyc scheme.3
this study aimed to identify and quantify the activities 
pertaining to the poyc scheme that are normally 
undertaken by the three chosen community pharmacies, 
together with any expenses incurred. the reimbursement 
by the government is consequently questioned to assess 
whether it is adequate.
Method
 
three pharmacies were identified for the purpose of this 
study. they were named pharmacy a, pharmacy b and 
pharmacy c for the sake of anonymity. when the study was 
carried out, the pharmacies had approximately 200, 500 
and 1,500 registered patients respectively.
a time and motion study was selected for the purpose of this 
research since it was found that this qualitative approach 
would provide the best information about the research 
question.4 the participants in the study were pharmacists 
who are directly involved in the poyc scheme. 
two templates, which included all the activities related to 
the poyc scheme, were designed. one template dealt with 
the back office work that is involved in the poyc scheme, 
whereas the other listed all the activities that revolve around 
the patient. both templates were validated and reliability 
tests were performed. these tests confirmed the accuracy 
and precision of the templates, consequently making them 
valid for future studies.
the time spent on poyc activities in the three pharmacies 
was quantified for a period of six working days in each 
pharmacy. the duration of the study was one week to take 
into consideration both busy and quiet days, to minimise 
unnecessary bias. 
8all the various costs and benefits incurred by the three 
pharmacies in relation to the poyc scheme were identified 
and quantified. the time spent on poyc-related activities 
was converted into monetary terms and the total costs 
incurred to implement this scheme were identified. these 
values were subsequently compared to the income from 
the government to determine whether the latter outweighs 
the costs. 
two different methods were used to calculate the direct 
costs incurred to implement the system in the three chosen 
pharmacies. method 1 was based on the total time taken 
on all the activities pertaining to the poyc scheme. this 
was applied to the three individual pharmacies. the second 
method was based on the average time taken per patient 
per pharmacy and the time taken to do back office work was 
separated from the time taken to deal with the patients.
Figure 1: percentages of patients and the total time spent in the three pharmacies
Figure 2: mean time (minutes) of each task
Results
a total of 598 patients were involved in the study; 86 
patients were from pharmacy a, 190 patients were from 
pharmacy b and 322 patients were from pharmacy c. the 
total time that was attributed to all poyc-related activities 
in the three pharmacies was 2900 minutes. about 14% of 
the total time was spent in pharmacy a, 35% in pharmacy b 
and about 51% in pharmacy c (figure 1). 
the weighted average time of each activity relating to the 
poyc scheme was calculated. the results show that some 
tasks take longer to complete than others. the frequency 
of most of the tasks occurring in the individual pharmacies 
varied considerably since the pharmacies had a different 
number of patients registered with the poyc scheme. 
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the resulting p value of 0.000 indicates that the mean 
durations to perform the different tasks vary significantly. 
if confidence intervals are disjoint, i.e. they do not overlap, 
this indicates that the mean durations differ significantly. 
the fact that the confidence intervals do not overlap, 
explains why the one - way anova test yields a significant 
result (p<0.05) (figure 2).  
the average time per patient was 3.53 minutes for pharmacy 
a, 4 minutes for pharmacy b and 3.98 minutes for pharmacy 
c. the p value, 0.509, exceeds the 0.05 level of significance 
and indicates that the mean duration per patient do not 
differ significantly between the three pharmacies. the fact 
that the three confidence intervals overlap explains why the 
one - way anova test yields a result which is not significant 
(p>0.05) (figure 3). 
the cost models for both methods are shown in table 1. 
overheads are not included.
PHARMACY METHOD 1 (€) METHOD 2 (€)
REMUNERATION BY 
THE GOVERNMENT (€)
A 4,991.48 2,203 4,660
B 12,772.76 6,115 11,650
C 18,691.92 11,261 34,950
Table 1: cost models for the pharmacies and comparison with the remuneration by the government
Discussion
from this study, it is evident that the poyc scheme involves 
several activities that are related to back office work. these 
take up a relatively large proportion of the total time that 
is attributable to the poyc scheme. nevertheless, such 
activities are necessary and their importance cannot be 
underestimated. back office work and other activities that 
do not directly involve the patient, such as inputting the 
dispensed quantities of medication in the computer can be 
carried out by staff, other than the pharmacist. in this way, 
more time is dedicated to the patient and to pharmaceutical 
care.
the overheads for each pharmacy have increased since 
the start of the poyc scheme. this is particularly so 
for pharmacy b and c which have a large number of 
registered patients. such overheads include telephone 
calls, electricity consumption, floor space and an increased 
Figure 3: mean time per patient in three pharmacies
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number of employed staff, incurring extra expenses on 
wages. additional costs which include intangible costs, 
maintenance costs and opportunity costs must also be 
considered.
in method 2, it was assumed that each patient goes to the 
pharmacy to collect the medicines pertaining to the poyc 
scheme six times a year. this excludes the prescriptions for 
warfarin and controlled drugs, changes in treatment and 
out of stock forms. this is why method 2 gave different 
results from those of method 1.
the remuneration from the government may need to 
be questioned from different aspects. the remuneration 
for the patients who receive several medications is the 
same as for those who only take one type of medication. 
furthermore, a patient should theoretically go to the 
community pharmacy six times a year to collect the 
medicines that are required from the poyc scheme since a 
two-month supply is dispensed every time. however, due 
to the prescriptions for warfarin and controlled drugs, out 
of stock forms and changes in medication, a large number 
of patients present at the pharmacy several times a year, at 
times on a weekly basis, thus adversely impinging on the 
time-factor. the results obtained from method 2 indicate 
that the poyc scheme would be more profitable for the 
pharmacies if such prescriptions were not included. since 
this is not possible and it is not in the patients’ interests, 
the government may consider revisiting the remuneration 
to the pharmacies, thus making the poyc scheme more 
worthwhile and reinforcing the incentive for pharmacists.
the main limitation of this study is that the research was 
conducted in a very short time due to the limited amount of 
time that was available. consequently, a small sample size 
was used. in fact, only three community pharmacies were 
visited. generalisations to other community pharmacies 
that have implemented the poyc scheme are difficult to 
make. a wider spectrum covering a larger sample spread 
over a longer period of time, would give a clearer indication 
of the actual situation.
most of the overheads, such as the intangible costs and 
benefits, were only mentioned and were not quantified. 
future research should attempt to identify and quantify 
these costs and benefits. such studies ought to assess in 
detail the impact of the poyc scheme on the quality of life of 
the pharmacist who is involved in its daily implementation.
Conclusion  
 
despite the fact that the study was carried out over a 
short period of time, the use of a case study report allows 
the investigator to throw some light on the issues being 
explored. while there is no attempt to generalise the results 
to all pharmacies and pharmacists in the poyc scheme, it is 
hoped that this study will raise questions about the poyc 
scheme and open up a forum of discussion. 
Expenses incurred due to the system run into thousands 
of Euros every year. consequently, not much money is 
to be made through implementing the poyc scheme. 
this, however, should not be the case. the service given 
by the community pharmacies should be adequately 
compensated for, thus making the implementation of the 
poyc scheme a worthwhile investment that is rewarding 
for all stakeholders.
this study was carried out when the remuneration by 
the government was €23.30 per patient per year.  in the 
future, such payment will increase to €25.63 per patient 
per year, and later even to €27.96 per patient per year. this 
however does not necessarily result in larger profits as the 
incurred costs due to the poyc scheme may also increase. 
furthermore, such costs may increase to the extent that the 
community pharmacies will be worse off than the current 
scenario. it is therefore recommended that such studies are 
done and analysed on a regular basis.  
discussions on a broader level regarding the proper 
implementation of the poyc scheme can be organised. in 
conducting these workshops, the inclusion of stakeholders, 
particularly pharmacists who are operating the system in 
the pharmacies is recommended so that an interactive 
dialogue will act as an ongoing process to the continued 
development of the poyc scheme.  
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